PLOD1 and polycystic ovary syndrome: Sodium butyrate capsules (2 g/day) delivered for 12 weeks lowered fasting insulin by 3.1 μIU/mL and reduced the LH/FSH ratio in Iranian women with PCOS (Dastgheib et al., 2019).